Investing
1209 Articles
Dividends are still rising and equity and income investors should expect more of the same for 2012. The Walt Disney Company…
It now costs about $1 billion to get a new drug to market, or, if a company is unlucky, $1…
The economic choppiness is coming to a head with the age of dividend hikes. The pressure is going to remain…
Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) and Warren Buffett have just released the latest holdings of U.S.-listed equities as of September…
Italy and Greece begin efforts to prove that their sovereign debt is safe. (Reuters) Groupon (NASDAQ: GRPN) will make a…
Drug maker Eli Lilly & Co. (NYSE: LLY) reported third-quarter earnings this morning, and the company did a little better…
It’s that time of year again, when proxies are released and many business publications run lists of the highest paid…
Today was a day of red that went to a day of green. Earnings were at first a disappointment, and…
Jon OggEarnings season is upon us and so far things are shaping up either a bit better, or less-bad, than…
Sales for the big pharmaceutical companies are expected to be hit by pricing pressure in Europe, a lack of urgent…
With fears of a new economic downturn, investors have become concerned about sales and profits of large companies. But there…
Angela Merkel faces a test: will her own party support money being used for the bailout of Greece? (Reuters) Bernanke…
Jon OggThese are some of this Thursday’s top analyst upgrades, downgrades, and initiations seen having an impact from Wall Street…
The 30-Year Treasury auction, the so-called Long Bond, had a strong participation for what is technically a 29-year and 11-month…
Medical device maker Boston Scientific Corp. (NYSE: BSX) has named a new president who will take over on October 17th…
Our top personal finance-related articles today. Your wallet will thank you later.